
Please try another search
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Nancy Chung-Welch | 63 | 2020 | Independent Director |
Marc S. Malandro | - | 2018 | Member of Scientific Advisory Board |
Daniel E. Handley | 64 | 2020 | Independent Director |
Robert F. Murphy | - | 2018 | Member of Scientific Advisory Board |
Charles L. Nuzum | 75 | 2020 | Lead Independent Director |
Gregory S. St. Clair | 58 | 2020 | Independent Director |
Raymond F. Vennare | 72 | 2021 | CEO & Chairman |
Bernard Anthony Harris | 67 | 2023 | Member of Business Advisory Board |
Andrew J. Einhorn | 64 | 2023 | Member of Business Advisory Board |
Christoph Reinhard | - | 2023 | Member of Scientific Advisory Board |
Matthew J. Hawryluk | 46 | 2022 | Independent Director |
Veena Rao-Mirmira | 56 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review